| CAS NO: | 2640217-64-5 |
| 包装 | 价格(元) |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 生物活性 | FGFR-IN-8 (Compound 17a) is a highly potent and orally active panFGFRinhibitor against wild-type and mutant FGFRs. FGFR-IN-8 shows inhibition withIC50values of<0.5, 189.1,<0.5, 22.6,<0.5 and 7.30 nM againstFGFR1, V564F-FGFR2, N549H-FGFR2, V555M-FGFR3,FGFR3andFGFR4, respectively. GFR-IN-8 inducescancercellapoptosisand shows anticancer activities[1]. | |||||||||
| IC50& Target |
| |||||||||
| 分子量 | 584.50 | |||||||||
| Formula | C27H31Cl2N9O2 | |||||||||
| CAS 号 | 2640217-64-5 | |||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | |||||||||
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
